The future of the global assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets. The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the assisted reproductive
technology market by product (instrument, accessory & disposable, and
reagents & media), technology (in vitro-fertilization, artificial
insemination, and others), end use industry (fertility clinic, hospital, surgical
center, clinical research institute, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, in
vitro-fertilization, artificial insemination are the major segments of assisted
reproductive technology market by technology. Lucintel forecasts that in
vitro-fertilization will remain the larger segment over the forecast period due
to reducing fertility rate, growing sedentary lifestyle, growing trend of
delayed pregnancy and low cost of IVF procedure. Within this market, fertility
clinic will remain the largest segment due to growing prevalence of
reproductive cases, rising unhealthy lifestyle, and increase in the number of
fertility clinics.
Europe is expected to
witness highest growth over the forecast period due to growing prevalence of
infertility, increasing disposable incomes, and rising funds from government
and private organization for in-vitro fertilization (IVF), and advancements in
technology for infertility in the region.
Cosmos Biomedical,
Microm U.K., CooperSurgical, FUJIFILM Irvine Scientific, Cryolab, Vitrolife AB,
European Sperm Bank, Bloom IVF Centre, Merck, and Ferring B.V. are the major
suppliers in the assisted reproductive technology market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment